As Europe’s cannabis sector pushes toward stronger legal and quality benchmarks, one issue draws concern but remains under-emphasized by operators: microbial contamination in cannabis inflorescences. Most producers remain focused on THC levels, terpene expression, and...
Global Cannabis Market Trends: Emerging Opportunities In Europe, Africa, South America & Asia As 2025 unfolds, the medical cannabis sector is entering a critical new phase. While growth in legacy markets has plateaued, a new wave of emerging regions is stepping...
Australia’s medical cannabis industry is on a remarkable growth trajectory, with revenues projected to double from approximately USD $600 million in 2024 to over USD $1.2 billion by 2028, according to the Global Cannabis Report: 5th Edition by Prohibition...
The Greek medical cannabis industry is experiencing rapid growth, with Curity Pharma emerging as a key player in its evolution. On March 4, 2025, Curity Pharma announced that it had secured its operating license from Greek regulatory authorities. This milestone grants...
Neobi is excited to contribute to this year’s CCX Annual Report with data driven insights derived from several of our data sources. The Extracts category saw strong early-year growth but declined in Q4, likely due to seasonal demand or competition. Innovative product...
2024 marks a watershed moment for the international cannabis market. While describing any year as ‘pivotal’ risks cliché, for this year it’s undeniably compelling: trends long anticipated by the industry have continued to materialize now just at an accelerated pace....
